CVRX - CVRx, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$10.00
DETAILS
HIGH:
$10.00
LOW:
$10.00
MEDIAN:
$10.00
CONSENSUS:
$10.00
UPSIDE:
63.67%
About CVRx, Inc. (https://www.cvrx.com)
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Kevin Hykes | President, Chief Executive Officer & Director | 1966 | $2,635,721 USD |
| Philip Adamson | Chief Medical Officer | 1961 | $1,101,943 USD |
| Robert Allen John | Chief Revenue Officer | 1974 | $1,049,584 USD |
| Paul Verrastro | Chief Marketing & Strategy Officer | 1963 | $598,972 USD |
| Jared Oasheim | Chief Financial Officer | 1983 | $517,269 USD |
| Bonnie Handke | Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics | – | – |
| Brent Binkowski | Chief Operating Officer | 1969 | – |
| Gregory Morrison | Chief Human Resources Officer | 1964 | – |
| Jonelle R. Burnham | Vice President & General Counsel | 1971 | – |